Question 1

What is the catalog number for Human Monoclonal DLL4 Antibody (navicixizumab) [Janelia Fluor 635]?

Accepted Answer

The catalog number for Human Monoclonal DLL4 Antibody (navicixizumab) [Janelia Fluor 635] is NBP3-28485JF635.

Question 2

What sizes are available for Human Monoclonal DLL4 Antibody (navicixizumab) [Janelia Fluor 635]?

Accepted Answer

Human Monoclonal DLL4 Antibody (navicixizumab) [Janelia Fluor 635] is available in the following size(s): 0.1 mL.

Question 3

Is Human Monoclonal DLL4 Antibody (navicixizumab) [Janelia Fluor 635] in stock?

Accepted Answer

Human Monoclonal DLL4 Antibody (navicixizumab) [Janelia Fluor 635] is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 5

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 6

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Human Monoclonal DLL4 Antibody (navicixizumab) [Janelia Fluor 635]

Product Specifications

Frequently Asked Questions

Explore Other Products

Fibronectin (2755-8), CF405S conjugate, 0.1mg/mL

CD44 / HCAM Std. (Cancer Stem Cell Marker) (rHCAM/918), CF594 conjugate, 0.1mg/mL

Cytokeratin 8 (KRT8) (rB22.1), CF594 conjugate, 0.1mg/mL

S100A4 (Marker of Tumor Metastasis) (S100A4/2750R), 0.2mg/mL

CD31 / PECAM-1 (C31.10), CF488A conjugate, 0.1mg/mL

CD74 (CLIP/813), 0.2mg/mL